Sign Up to like & get
recommendations!
1
Published in 2017 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.6b01016
Abstract: Doxorubicin (DOX) is a broad-spectrum chemotherapy drug to treat tumors. However, severe side effects and development of DOX resistance hinder its clinical application. In order to overcome DOX resistance, DOX/TPP-DOX@Pasp-hyd-PEG-FA micelles were prepared by using…
read more here.
Keywords:
hyd peg;
dox;
tpp dox;
pasp hyd ... See more keywords